NewEdge Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+3,470
New +$146K ﹤0.01% 2761
2026
Q1
Sell
-14
Closed -$590 4409
2025
Q4
$590 Buy
+14
New +$564 ﹤0.01% 4036
2025
Q1
Sell
-2
Closed -$79 4114
2024
Q4
$79 Hold
2
﹤0.01% 3797
2024
Q3
$68 Sell
2
-19
-90% -$535 ﹤0.01% 3736
2024
Q2
$455 Sell
21
-122
-85% -$2.56K ﹤0.01% 3575
2024
Q1
$3.17K Sell
143
-75
-34% -$1.83K ﹤0.01% 3279
2023
Q4
$6K Sell
218
-12,359
-98% -$298K ﹤0.01% 3063
2023
Q3
$281K Buy
12,577
+12,567
+125,670% +$323K ﹤0.01% 1463
2023
Q2
$255 Sell
10
-2,099
-100% -$50.9K ﹤0.01% 3367
2023
Q1
$47K Sell
2,109
-500
-19% -$12.1K ﹤0.01% 2033
2022
Q4
$11.5K Buy
+2,609
New +$60.6K ﹤0.01% 2324

Other funds holding VCYT

NewEdge Advisors's VCYT Position: Q2 2026 in Review

NewEdge Advisors opened a new position in Veracyte (VCYT) in Q2 2026: 3,470 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #2761 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in VCYT as recently as Q4 2025.

NewEdge Advisors first reported a position in VCYT in Q4 2022 and has held it in 11 quarters since. The position peaked at $281K in Q3 2023. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • NewEdge Advisors held 3,470 shares of Veracyte worth $204K as of Q2 2026.
  • Veracyte was a new NewEdge Advisors position in Q2 2026.
  • Veracyte made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2761 holding.
  • NewEdge Advisors first reported a position in Veracyte in Q4 2022 and has held it in 11 quarters since.
  • NewEdge Advisors's Veracyte position peaked at $281K in Q3 2023.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.